Nimotuzumab in Children With HGG

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00561873
Recruitment Status : Completed
First Posted : November 21, 2007
Last Update Posted : November 21, 2007
Children`s Medical Hospital, University of Bonn, Germany
University of Wuerzburg
University of Bonn
Dept. of Statistics, University of Dortmund, Germany
CRM Biometrics GmbH
Heinrich-Heine University, Duesseldorf
Klinikum Augsburg
Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany
Children`s Medical Hospital, University of Homburg/Saar, Homburg/Saar, Germany
Hannover Medical School
Children's Medical Hospital, University of Essen, Essen, Germany
Dept. of Neuropediatrics and Muscle Disorders, University of Freiburg, Germany
University of Cologne
Universitätsklinikum Hamburg-Eppendorf
University of Regensburg
Information provided by:
Oncoscience AG

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : February 2007